Naveni PD1/PD-L1 HRP from CAYMAN CHEMICAL COMPANY
Search, find, compare suppliers for Naveni PD1/PD-L1 HRP products.
| Edit | |
|---|---|
| Product Name | Naveni PD1/PD-L1 HRP |
| Description | The PD1/PD-L1 HRP is an in situ proximity ligation assay kit for chromogenic detection of the interaction of PD1 and PD-L1. This is the first commercial assay for detecting the interaction in situ, the kit gives a high signal-to-noise ratio and has an out-standing specificity. The kit has been validated on FFPE human tissue samples. ,,,The kit is based on our Naveni™ Proximity Ligation Technology, with two Navenibodies conjugated to proprietary oligo arms. The technology ensures specific and sensitive detection; learn more about Naveni technology. ,,,One Navenibody binds the PD1 protein, and the other Navenibody binds PD-L1 . Probes in close proximity will give a strong and distinct signal, creating a specific and sensitive detection method for the interaction between PD1 and PD-L1.,,,Included in the kit:,• Navenibody targeting human PD1 protein based on clone EH33 CST,• Navenibody targeting human PD-L1 protein based on clone SP142 Abcam RabMAb®,• HRP substrate, red precipitating reaction product ,• Buffers for blocking and dilutions, and all detection reagents,• The Navenibody solution has a working volume of 4000 µl (sufficient for approximately 100 reactions),,,Not included in the kit:,• VectaMount® Express Mounting Medium (H-5700-60) from Vector Laboratories (required for optimal signal intensity).,• Isopropanol 99.5%,• Endogenous quenching solution,• TBS and TBS-T-Tris-buffered saline and Tris-buffered saline supplemented with 0.05% Tween, respectively,,Also available with AP Substrate (Item No. 39215),,Find better prognostic biomarkers,PD1 PD-L1 signaling has with immune checkpoint inhibitors proven to be significant in cancer progression and treatment. Despite the recent success of immune checkpoint inhibitors, many patients do not benefit from these therapies, and predictive biomarkers improving patient stratification are needed.PD-L1 IHC is commonly used as a biomarker, but the correlation between PD-L1 expression levels and PD1/PD-L1 interaction is not always linear.,,,Naveni PPI,Proteins perform a wide range of functions and are the closest way to understand biology. Proteins are also key targets in both health and disease. When proteins carry out their function, they interact with other proteins or molecules. To understand biological pathways and mode of action, we need to get a deeper insight into protein functions and how the protein interacts. Detecting the interactions has until now been either complicated, unspecific, or insensitive. The Naveni™ Proximity Ligation Technology enables visualization of protein-protein interaction using one primary antibody for each target protein, without the need to disrupt the tissue microenvironment. |
| Size | 100 RXN |
| Concentration | n/a |
| Applications | Immunohistochemistry |
| Other Names | proximity ligation assay protein-protein interaction PPI in situ bright-field chromogenic immunohistochemistry immuno-histochemistry western blot WB validated antibodies immunooncology immuno-oncology immuno-therapy immunotherapy patient stratification biomarker bio-marker drug target engagement tissue microenvironment single cell resolution BRET FRET co-IP coIP Navinci |
| Gene, Accession, CAS # | n/a |
| Catalog # | 39216-100 |
| Price | $2,299.00 |
| Order / More Info | Naveni PD1/PD-L1 HRP from CAYMAN CHEMICAL COMPANY |
| Product Specific References | n/a |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Profile of CAYMAN CHEMICAL COMPANY